Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Gallagher

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Rheumatology Advances in Practice|January 15, 2026
Development of a clinical tool to identify patients with early inflammatory arthritis at high risk of employment loss: analysis from the National Early Inflammatory Arthritis AuditEd Alveyn, Katie Bechman, Maryam Adas, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Journal of Infectious Diseases|February 8, 2022
Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical TrialBianca F Middleton, Margie Danchin, Mark A Jones, et al.
Vaccine|May 13, 2023
Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccinationBianca F Middleton, Margie Danchin, Nigel A Cunliffe, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Global distribution of <i>Leptospira</i> serovar isolations and detections from animal host species: a systematic review and online databaseNienke N Hagedoorn, Michael J Maze, Manuela Carugati, et al.
Tropical Medicine & International Health : TM & IH|February 14, 2024
Global distribution of Leptospira serovar isolations and detections from animal host species: A systematic review and online databaseNienke N Hagedoorn, Michael J Maze, Manuela Carugati, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Life Sciences in Space Research|January 22, 2023
The COSPAR Planetary Protection Policy for robotic missions to Mars: A review of current scientific knowledge and future perspectivesKaren Olsson-Francis, Peter T Doran, Vyacheslav Ilyin, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Rheumatology Advances in Practice|January 15, 2026
Development of a clinical tool to identify patients with early inflammatory arthritis at high risk of employment loss: analysis from the National Early Inflammatory Arthritis AuditEd Alveyn, Katie Bechman, Maryam Adas, et al.
Rheumatology (Oxford, England)|November 1, 2024
Temporal and regional variation in the use of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort studyMark D Russell, Zijing Yang, Niamh Dooley, et al.
The Lancet. Rheumatology|October 18, 2024
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort studyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Lancet. Rheumatology|February 8, 2025
Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis - Authors' replyMark D Russell, Mark Gibson, Benjamin Zuckerman, et al.
The Journal of Infectious Diseases|February 8, 2022
Immunogenicity of a Third Scheduled Dose of Rotarix in Australian Indigenous Infants: A Phase IV, Double-blind, Randomized, Placebo-Controlled Clinical TrialBianca F Middleton, Margie Danchin, Mark A Jones, et al.
Vaccine|May 13, 2023
Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccinationBianca F Middleton, Margie Danchin, Nigel A Cunliffe, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Global distribution of <i>Leptospira</i> serovar isolations and detections from animal host species: a systematic review and online databaseNienke N Hagedoorn, Michael J Maze, Manuela Carugati, et al.
Tropical Medicine & International Health : TM & IH|February 14, 2024
Global distribution of Leptospira serovar isolations and detections from animal host species: A systematic review and online databaseNienke N Hagedoorn, Michael J Maze, Manuela Carugati, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Life Sciences in Space Research|January 22, 2023
The COSPAR Planetary Protection Policy for robotic missions to Mars: A review of current scientific knowledge and future perspectivesKaren Olsson-Francis, Peter T Doran, Vyacheslav Ilyin, et al.
Pageof 4